Drug profile · INN
dexchlorpheniramine maleate
DEXCHLORPHENIRAMINE MALEATE
dexchlorpheniramine maleate (DEXCHLORPHENIRAMINE MALEATE) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — dexchlorpheniramine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
dexchlorpheniramine maleate (DEXCHLORPHENIRAMINE MALEATE) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dexchlorpheniramine maleate?
dexchlorpheniramine maleate (DEXCHLORPHENIRAMINE MALEATE) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dexchlorpheniramine maleate?
DEXCHLORPHENIRAMINE MALEATE is a marketed brand name for dexchlorpheniramine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dexchlorpheniramine maleate?
dexchlorpheniramine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.